Logo Beilstein Institut

Straightforward and robust synthesis of monodisperse surface-functionalized gold nanoclusters

  1. 1,2 ,
  2. 3 ,
  3. 1 ,
  4. 1 and
  5. 1,2
1Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Mühlenberg 1, 14476 Potsdam, Germany
2Freie Universität Berlin, Department of Biology, Chemistry, Pharmacy, Arnimallee 22, 14195 Berlin, Germany
3Helmholtz Centre Potsdam GFZ German Research Centre for Geosciences, Sec. 4.3, Telegrafenberg, 14473 Potsdam, Germany
  1. Corresponding author email
Associate Editor: J. J. Schneider
Beilstein J. Nanotechnol. 2016, 7, 1278–1283. https://doi.org/10.3762/bjnano.7.118
Received 29 Apr 2016, Accepted 17 Aug 2016, Published 08 Sep 2016

Abstract

Gold nanoclusters are small (1–3 nm) nanoparticles with a high surface area that are useful for biomedical studies and drug delivery. The synthesis of small, surface-functionalized gold nanoclusters is greatly dependent on the reaction conditions. Here, we describe a straightforward, efficient and robust room temperature one-pot synthesis of 2 nm gold nanoclusters using thioglucose as a reducing and stabilizing agent, which was discovered by serendipity. The resultant monodisperse gold nanoclusters are more stable than those generated using some other common methods. The carboxylic acid contained in the stabilizing agent on the cluster surface serves as anchor for nanocluster functionalization. Alternatively, the addition of thiols serves to functionalize the nanoclusters. The resulting non-cytotoxic nanoclusters are taken up by cells and constitute a tuneable platform for biomedical applications including drug delivery.

Keywords: biomedical applications; carbohydrates; functionalization; gold nanoclusters; robust

Findings

Nanoparticles ranging in size from 1 to 100 nm are ideal tools to study biological processes [1,2]. Many different materials, including gold, have been used to create nanoparticles [3-6]. Gold nanoparticles are an attractive platform because of their biocompatibility, low toxicity, and low immunogenicity [7], their inherent optoelectronic properties [8] and high transmission electron microscopy (TEM) contrast. They are relatively easy to synthesize, functionalize, are biocompatible and have controllable optical properties [3,9-12]. Therefore, gold nanoparticles functionalized with carbohydrates [13], proteins [14], antibodies [15] and DNA [16] are commonly used as multivalent materials for biological studies. Gold nanoparticles have been used in vivo as radiotracers [15,17], for targeted delivery [18] and, when functionalized with carboxylic acids, inhibit β-amyloid fibril growth related to Alzheimer’s disease [19]. Gold nanoclusters (NCs) are gold nanoparticles ranging in size between 1 and 3 nm, with interesting physicochemical properties and increased surface area for drug delivery applications [20].

There are several methods to synthesize gold nanoparticles. In addition to the reduction of HAuCl4 with citrate at high temperatures [21], sodium borohydride can act as a reducing agent while an alkanethiol stabilizes the nanoparticles [22]. The latter method was used to prepare glyconanoparticles by adding thiol-terminated glycoconjugates [23]. Gold nanoparticles have also been prepared under reflux using 1-thioglucose as reducing and stabilizing agent [24] but the resulting nanoparticles are too unstable to be used as biosensors [25].

In an effort to create monodisperse, stable and surface-functionalized gold nanoclusters, we explored 1-thioglucose as a stabilizing and reducing agent. By serendipity we discovered a novel one-pot method to prepare gold nanoclusters using 1-thioglucose at room temperature. This simple and robust synthesis produces stable, and monodisperse nanoclusters. Oxidation of the carbohydrate results in carboxylic acid as determined by X-ray photoelectron spectroscopy (XPS). Coupling to the carboxylic acids or addition of thiols functionalizes the NCs that are taken up by cells but are less cytotoxic than NCs prepared by other methods.

During experiments exploring different methods for the synthesis of gold tetrapods [26], we found that simply the addition of 1-thioglucose as reducing agent to gold salts resulted in the formation of monodisperse gold NCs (Figure 1A). The reaction produced the same products at any temperature between 0 and 90 °C and thereby stood in stark contrast to all known literature procedures [27-29] that were sensitive to all reaction conditions including the speed of the stirrer. The influence of the gold to 1-thioglucose ratio on the yield and quality of the glucose-stabilized gold nanoclusters (Glc-NCs) was determined (Table S1, Supporting Information File 1). The nanoclusters aggregated within 5 h at very high ratios of gold ions to 1-thioglucose (Figure S1, Supporting Information File 1). At higher gold ion concentrations, NCs that are not fully coated with stabilizer aggregate. At high thioglucose concentrations, NCs do not form. Monodisperse gold NCs (2.02 ± 0.18 nm) were obtained as determined by high resolution TEM (Figure 1C,D) and dynamic light scattering (DLS) (Figure S4, Supporting Information File 1). The one-pot synthesis of Glc-NCs is independent on the temperature between 0 and 90 °C (Figure S5, Supporting Information File 1).

[2190-4286-7-118-1]

Figure 1: A) One-pot synthesis of Glc-NCs at room temperature; B) UV–vis spectra of freshly synthesized Glc-NCs and after three days are indicative of stable particles; C) high-resolution TEM bright-field image of Glc-NCs showing monodisperse nanoclusters, scale bar 2 nm; D) size distribution of 110 nanoclusters of Glc-NCs yielding diameters of 2.02 ± 0.18 nm.

The Glc-NCs are more stable than nanoclusters that were stabilized with cetyltrimethylammonium bromide (CTAB-NCs) and tetrakis(hydroxymethyl)phosphonium chloride (THPC-NCs) as determined by UV absorbance. Gold nanoparticles smaller than 5 nm do not display a plasmon band. The Glc-NCs are stable and showed the same absorbance profile after three days of dialysis (Figure 1B). In contrast, the CTAB-NCs and the THPC-NCs exhibit plasmon bands (Figure S6, Supporting Information File 1). The CTAB-NCs showed a plasmon band directly after synthesis, which shifted to longer wavelengths after three days, suggesting an increasing rate of aggregation. TEM images of freshly prepared CTAB-NCs revealed polydisperse nanoclusters in terms of both size and shape (data not shown). The absorbance profile of THPC-NCs did not show a plasmon band after the synthesis. However, after three days, a plasmon band appeared, revealing particle aggregation. The surface charge did not change upon dialysis for any sample as indicated by the zeta potential (Figure S7, Supporting Information File 1).

To better understand the role of the stabilizing agent used to prepare Glc-NCs, XPS was employed (Figure S8, Supporting Information File 1). The gold core of the nanoclusters (confirmed by the Au 4f scan) is stabilized through an Au–S bond (162.5 eV, S 2p scan). C–O bonds and a carbonyl group were detected on the nanocluster surface by C 1s (286 eV and 288.5 eV, respectively) and O 1s (531.5 eV and 533 eV, respectively) scans (Table S2 and Table S3, Supporting Information File 1). The carbonyl signal likely is indicative of the oxidation of hydroxy groups of the carbohydrate as the precursor 1-thio-glucose contains no carbonyl group. The carboxylic acid in the stabilizing agent was confirmed by the XPS O–C=O signal and IR bands at 3270, 1732 and 1014 cm−1 (Figure S9, Supporting Information File 1). To confirm the XPS and IR analyses, trifluoroethanol was coupled to form Glc-NC@F to be monitored by using 19F NMR (Figure 2A,B). The 19F NMR signal of the starting material shifts after 30 min to show both starting material and product peaks (Figure S10a, Supporting Information File 1). Only the product peak remained after dialysis. Twenty stabilizer molecules per nanocluster were measured by comparing the number of trifluoroethanol molecules coupled to Glc-NCs using an internal standard (Figure S10b, Supporting Information File 1). Thus, we demonstrated that Glc-NCs can be functionalized via coupling to carboxylic acid groups.

[2190-4286-7-118-2]

Figure 2: A) Functionalization of Glc-NCs by coupling trifluoroethanol to the carboxylic acid groups on the surface of the nanocluster to yield Glc-NC@F and via thio-substitution of pentylthiol mannoside on the gold surface giving Glc-NC@Man; B) 19F NMR of Glc-NC@F after dialysis showing one product peak; C) vials containing (1) Glc-NCs (2) Glc-NC@Man (3) Glc-NCs + ConA (4) Glc-NC@Man + ConA. Aggregation is only observed upon addition of the lectin ConA (4).

To illustrate the surface functionalization of Glc-NCs, pentylthiol mannoside (Scheme S1, Supporting Information File 1) was incubated with Glc-NCs overnight to yield Glc-NC@Man (Figure 2A). After dialysis, the IR spectrum revealed two new peaks corresponding to the C–H bonds of the linker at 2856 and 2925 cm−1. Apparently, all carbohydrates reacted as no S–H peaks were observed (Figure S11, Supporting Information File 1). Functional evidence for the formation of Glc-NC@Man was obtained by aggregating Glc-NC@Man with the addition of the mannose-binding lectin concanavalin A (ConA). Unfunctionalized Glc-NCs fail to aggregate since oxidized thio-glucose is not recognized by ConA (Figure 2C). Glc-NC@Man are monodisperse prior to aggregation by the addition of ConA as judged by TEM (Figure S12, Supporting Information File 1).

Nanocluster cytotoxicity was assessed by incubating the nanoclusters for one day with the mouse cell line L929 for a proof-of-principle study. Cell viability was measured using the MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt] assay [30]. The cytotoxicity of Glc-NCs, CTAB-NCs and THPC-NCs was compared. CTAB-NCs were toxic even at low concentrations (0.2–25 µM), whereas both THPC-NCs (Figure S13, Supporting Information File 1) and Glc-NCs did not show any toxicity at 500 µM (Figure 3A). To test whether the free stabilizers were affecting the cytotoxicity, both Glc-NCs and THPC-NCs were measured after synthesis without dialysis. Glc-NCs were not cytotoxic at any concentration tested (Figure 3B), whereas THPC-NCs were toxic at 100 µM (Figure S14, Supporting Information File 1), indicating that Glc-NCs are suitable for biological experiments even without purification.

[2190-4286-7-118-3]

Figure 3: Cell viability of Glc-NCs A) purified and B) without purification incubated for one day with L929 cells. The Glc-NCs were not toxic at any of the concentrations studied. C) Cellular uptake of Glc-NCs when incubated with L929 cells for one day. Gold concentration taken up by the cells was measured with ICP-OES and showed an uptake of 108–109 gold atoms per cell.

Cellular uptake of the nanoclusters was studied by incubating 12.5 and 25 µM Glc-NCs with the same cell line. After 24 h, the cells were washed with buffer and then treated with aqua regia to transform the gold nuclei into gold ions that were detected by an inductively coupled plasma optical emission spectrometer (ICP-OES). The Glc-NCs are cell permeable as 108–109 gold atoms were delivered per cell and can potentially be used in cellular delivery applications (Figure 3C).

In summary, we developed a straightforward, robust and efficient one-pot method to prepare glucose-stabilized gold nanoclusters (Glc-NCs). The resulting 2 nm nanoclusters are monodisperse and more stable than gold nanoclusters synthesized by other methods. Functionalization of the Glc-NCs is achieved either via coupling to the carboxylic acid of the stabilizing agent or substitution with a thio-functionalized molecule. Glc-NCs are non-toxic, but are taken up by L929 cells. Surface functionalization of Glc-NCs with biomolecules opens opportunities for drug delivery applications.

Supporting Information

Supporting Information File 1: Additional experimental data.
Format: PDF Size: 799.6 KB Download

Acknowledgements

We thank the Max Planck Society for generous funding. The authors would like to thank the group of Prof. Luisa De Cola for XPS measurements, Ms. Jeannette Steffen for ICP-OES assistance and Dr. Maria A. Carillo, Dr. Martina Delbianco, and Dr. Richard Fair for fruitful discussions.

References

  1. Katz, E.; Willner, I. Angew. Chem., Int. Ed. 2004, 43, 6042–6108. doi:10.1002/anie.200400651
    Return to citation in text: [1]
  2. de la Fuente, J. M.; Penadés, S. Biochim. Biophys. Acta 2006, 1760, 636–651. doi:10.1016/j.bbagen.2005.12.001
    Return to citation in text: [1]
  3. Yeh, Y.-C.; Creran, B.; Rotello, V. M. Nanoscale 2012, 4, 1871–1880. doi:10.1039/C1NR11188D
    Return to citation in text: [1] [2]
  4. Iravani, S.; Korbekandi, H.; Mirmohammadi, S. V.; Zolfaghari, B. Res. Pharm. Sci. 2014, 9, 385–406.
    Return to citation in text: [1]
  5. Hao, R.; Xing, R.; Xu, Z.; Hou, Y.; Gao, S.; Sun, S. Adv. Mater. 2010, 22, 2729–2742. doi:10.1002/adma.201000260
    Return to citation in text: [1]
  6. Rao, J. P.; Geckeler, K. E. Prog. Polym. Sci. 2011, 36, 887–913. doi:10.1016/j.progpolymsci.2011.01.001
    Return to citation in text: [1]
  7. Shukla, R.; Bansal, V.; Chaudhary, M.; Basu, A.; Bhonde, R. R.; Sastry, M. Langmuir 2005, 21, 10644–10654. doi:10.1021/la0513712
    Return to citation in text: [1]
  8. Liz-Marzán, L. M. Mater. Today 2004, 7, 26–31. doi:10.1016/S1369-7021(04)00080-X
    Return to citation in text: [1]
  9. Daniel, M.-C.; Astruc, D. Chem. Rev. 2004, 104, 293–346. doi:10.1021/cr030698+
    Return to citation in text: [1]
  10. Boisselier, E.; Astruc, D. Chem. Soc. Rev. 2009, 38, 1759–1782. doi:10.1039/b806051g
    Return to citation in text: [1]
  11. Dykman, L.; Khlebtsov, N. Chem. Soc. Rev. 2012, 41, 2256–2282. doi:10.1039/C1CS15166E
    Return to citation in text: [1]
  12. Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W. J. Chem. Soc. Rev. 2008, 37, 1896–1908. doi:10.1039/b712170a
    Return to citation in text: [1]
  13. Marradi, M.; Chiodo, F.; García, I.; Penadés, S. Chem. Soc. Rev. 2013, 42, 4728–4745. doi:10.1039/c2cs35420a
    Return to citation in text: [1]
  14. Calzolai, L.; Franchini, F.; Gilliland, D.; Rossi, F. Nano Lett. 2010, 10, 3101–3105. doi:10.1021/nl101746v
    Return to citation in text: [1]
  15. El-Sayed, I. H.; Huang, X.; El-Sayed, M. A. Cancer Lett. 2006, 239, 129–135. doi:10.1016/j.canlet.2005.07.035
    Return to citation in text: [1] [2]
  16. Mirkin, C. A.; Letsinger, R. L.; Mucic, R. C.; Storhoff, J. J. Nature 1996, 382, 607–609. doi:10.1038/382607a0
    Return to citation in text: [1]
  17. Sherman, A. I.; Ter-Pogossian, M. Cancer 1953, 6, 1238–1240. doi:10.1002/1097-0142(195311)6:6<1238::AID-CNCR2820060618>3.0.CO;2-6
    Return to citation in text: [1]
  18. Brown, S. D.; Nativo, P.; Smith, J.-A.; Stirling, D.; Edwards, P. R.; Venugopal, B.; Flint, D. J.; Plumb, J. A.; Graham, D.; Wheate, N. J. J. Am. Chem. Soc. 2010, 132, 4678–4684. doi:10.1021/ja908117a
    Return to citation in text: [1]
  19. Liao, Y.-H.; Chang, Y.-J.; Yoshiike, Y.; Chang, Y.-C.; Chen, Y.-R. Small 2012, 8, 3631–3639. doi:10.1002/smll.201201068
    Return to citation in text: [1]
  20. Kim, B. H.; Hackett, M. J.; Park, J.; Hyeon, T. Chem. Mater. 2014, 26, 59–71. doi:10.1021/cm402225z
    Return to citation in text: [1]
  21. Turkevich, J.; Stevenson, P. C.; Hillier, J. Discuss. Faraday Soc. 1951, 11, 55–75. doi:10.1039/df9511100055
    Return to citation in text: [1]
  22. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. J. Chem. Soc., Chem. Commun. 1994, 801–802. doi:10.1039/C39940000801
    Return to citation in text: [1]
  23. de la Fuente, J. M.; Barrientos, A. G.; Rojas, T. C.; Rojo, J.; Cañada, J.; Fernández, A.; Penadés, S. Angew. Chem., Int. Ed. 2001, 40, 2257–2261. doi:10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S
    Return to citation in text: [1]
  24. Watanabe, S.; Yoshida, K.; Shinkawa, K.; Kumagawa, D.; Seguchi, H. Colloids Surf., B 2010, 81, 570–577. doi:10.1016/j.colsurfb.2010.07.061
    Return to citation in text: [1]
  25. Richards, S.-J.; Fullam, E.; Besra, G. S.; Gibson, M. I. J. Mater. Chem. B 2014, 2, 1490–1498. doi:10.1039/c3tb21821j
    Return to citation in text: [1]
  26. Liu, H.; Xu, Y.; Qin, Y.; Sanderson, W.; Crowley, D.; Turner, C. H.; Bao, Y. J. Phys. Chem. C 2013, 117, 17143–17150. doi:10.1021/jp405859x
    Return to citation in text: [1]
  27. Zhu, M.; Lanni, E.; Garg, N.; Bier, M. E.; Jin, R. J. Am. Chem. Soc. 2008, 130, 1138–1139. doi:10.1021/ja0782448
    Return to citation in text: [1]
  28. Wu, Z.; Suhan, J.; Jin, R. J. Mater. Chem. 2009, 19, 622–626. doi:10.1039/B815983A
    Return to citation in text: [1]
  29. Meng, X.; Liu, Z.; Zhu, M.; Jin, R. Nanoscale Res. Lett. 2012, 7, 277. doi:10.1186/1556-276X-7-277
    Return to citation in text: [1]
  30. Barltrop, J. A.; Owen, T. C.; Cory, A. H.; Cory, J. G. Bioorg. Med. Chem. Lett. 1991, 1, 611–614. doi:10.1016/S0960-894X(01)81162-8
    Return to citation in text: [1]

© 2016 Varela-Aramburu et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Nanotechnology terms and conditions: (http://www.beilstein-journals.org/bjnano)

Other Beilstein-Institut Open Science Activities
Journal Logo
Institut Logo
Preprint Logo
Symposia Logo